Position in PFE
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$858,909
-$198,555 QoQ
Shares Held
35,669
-5.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,418
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEAVELL INVESTMENT MANAGEMENT, INC. holds $56,783,148 across 9 Drug Manufacturers - General names. PFE ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
74,935 | $18,856,643 | |
| 2 | LLY |
ELI LILLY & Co
|
9,341 | $11,203,876 | |
| 3 | JNJ |
Johnson & Johnson
|
40,591 | $10,308,896 | |
| 4 | AMGN |
Amgen Inc
|
17,935 | $6,494,622 | |
| 5 | MRK |
Merck & Co., Inc.
|
41,794 | $5,370,529 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
36,579 | $2,107,681 | |
| 7 | AZN |
Astrazeneca PLC
|
6,562 | $1,244,286 | |
| 8 | PFE |
Pfizer Inc
This page
|
35,669 | $858,909 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $858,909 | 35,669 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $1,057,464 | 37,659 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $884,871 | 35,537 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,030,767 | 40,454 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,047,119 | 43,198 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,251,694 | 49,396 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,304,931 | 49,187 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $1,710,788 | 59,115 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,722,001 | 61,544 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $1,769,673 | 63,772 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $2,059,406 | 71,532 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $2,730,355 | 82,314 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $3,649,990 | 99,509 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $4,242,384 | 103,980 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $5,424,266 | 105,860 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $4,737,020 | 108,250 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $5,925,691 | 113,021 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $5,686,934 | 109,850 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $6,487,351 | 109,862 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $4,710,584 | 109,523 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $4,160,319 | 106,239 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $3,849,038 | 106,239 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $4,340,598 | 117,919 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $4,304,538 | 117,290 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $3,901,964 | 119,326 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $3,800,008 | 116,422 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||